Displaying items by tag: Covid vaccinations
Answered prayer
On 10 September Prayer Alert reported that government ministers were rejecting Scientists recommendations of Covid jabs for 12- to 15-year-olds. You prayed for the Government to change its mind and step in so that pupils got what was needed according to God’s plans for them (Jeremiah 29:11). On 14 September the Government announced that a Covid jab rollout will start in schools in England. Although they are deemed at very low risk from the disease, factors such as disruption to education tipped the balance.
Covid variant causing concern
Scientists are concerned that vaccines may be less effective against the Indian variant, which could become dominant in the UK by June. The double mutation Covid-19 variant is thought to be behind a sudden surge in cases in India which has overwhelmed hospitals. A total of 182 cases have been detected in the UK, 162 in the five weeks up to 16 April, forcing Boris Johnson to postpone his trip to India and the government to add India to its travel ‘red list’. Viruses regularly mutate but most are insignificant, however, some mutations can make the virus more infectious, deadly or resistant to vaccines. The Indian virus may be one of those - especially because two mutations have come together to help infect cells and evade the immune system.
Global: vaccination challenges for developing countries
Wealthy countries should be well-covered with vaccines by the first half of 2021, but low-income countries will still be waiting. Médecins Sans Frontières (MSF) said that vaccine access is a huge challenge for low- and middle-income countries. Even when people in high-income countries have access to adequate vaccinations, if Covid is still circulating in poorer countries we will not see an end to the pandemic. Oxfam said, ‘What we want to see AstraZeneca and Oxford do now is to commit to an open licence so more vaccine manufacturers can get on board. We think really the power is in their hands to end this epidemic by the end of 2021.’ Both MSF and Oxfam say that both price and supply challenges can be overcome if we look at more systemic issues of patents. We need to open up intellectual property, including patents, so any manufacturer around the world could produce successful products without fearing sanctions.